A Study into High Flow Humidified Nasal Oxygen Therapy (OptiflowTM) and its' Impact on Lung Pressures.

Phase 1

Completed

• Conditions: Acute Respiratory Failure; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12607000372482
• Lead Sponsor: Fisher and Paykel Healthcare Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-07-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Consent has been obtained • The patient is undergoing cardiac surgery requiring sternotomy.

Exclusion Criteria

Patients will be excluded from the study if one or more of the following criteria are present:• The patient has significant nasal septum deviation.• High flow nasal oxygen therapy is contraindicated. • Following surgery the patient is unable to follow simple commands once awake and extubated

Study & Design

• Study Type: Interventional
• Study Design: Not specified